A

Anticancer Bioscience

28 employees

Anticancer Biosciences is an precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Precision Oncology
MYC
Therapeutics
Synthetic Lethality
Natural Product Library
Pharmaceutical
Drug Discovery
Life Science

Date founded

2016

Funding rounds raised

Total raised

$11M

from 1 investors over 1 rounds

A

Anticancer Bioscience raised $11M on October 14, 2021

Investors: 3 Rivers Capital, LLC

FAQ